CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets
Cash and due from banks	$ 286,755	$ 256,264
Interest bearing deposits with banks	718,260	178,423
Investment securities:
Equity securities	49,701	41,410
Available for sale debt securities	1,749,842	1,566,801
Held to maturity debt securities (net of allowance for credit losses of $1,552 at March 31, 2020)	2,315,481
Held to maturity debt securities (net of allowance for credit losses of $1,552 at March 31, 2020)	2,317,033	2,336,095
Total investment securities	4,115,024	3,944,306
Loans held for sale, at fair value	58,868	76,113
Loans	30,428,067	29,699,208
Less: Allowance for loan losses	(283,342)	(161,759)
Net loans	30,144,725	29,537,449
Premises and equipment, net	332,503	334,533
Lease right of use assets	278,080	285,129
Bank owned life insurance	542,127	540,169
Accrued interest receivable	107,353	105,637
Goodwill	1,375,409	1,373,625
Other intangible assets, net	82,686	86,772
Other assets	1,078,839	717,600
Total Assets	39,120,629	37,436,020
Deposits:
Non-interest bearing	6,951,073	6,710,408
Interest bearing:
Savings, NOW and money market	13,498,830	12,757,484
Time	8,567,085	9,717,945
Total deposits	29,016,988	29,185,837
Short-term borrowings	2,095,655	1,093,280
Long-term borrowings	2,805,639	2,122,426
Junior subordinated debentures issued to capital trusts	55,805	55,718
Lease liabilities	303,096	309,849
Accrued expenses and other liabilities	422,448	284,722
Total Liabilities	34,699,631	33,051,832
Shareholders’ Equity
Common stock (no par value, authorized 650,000,000 shares; issued 403,765,978 shares at March 31, 2020 and 403,322,773 shares at December 31, 2019)	141,613	141,423
Surplus	3,624,036	3,622,208
Retained earnings	452,424	443,559
Accumulated other comprehensive loss	(6,566)	(32,214)
Treasury stock, at cost (21,830 common shares at March 31, 2020 and 44,383 common shares at December 31, 2019)	(200)	(479)
Total Shareholders’ Equity	4,420,998	4,384,188
Total Liabilities and Shareholders’ Equity	39,120,629	37,436,020
Series A
Shareholders’ Equity
Preferred stock, no par value; authorized 50,000,000 shares	111,590	111,590
Series B
Shareholders’ Equity
Preferred stock, no par value; authorized 50,000,000 shares	$ 98,101	$ 98,101